About EnteroTrack
EnteroTrack is a private company based in Aurora, Colorado. It has reported $6,910,000 raised in three offerings on Form D since July 2014. Its chief executive is Robin Shandas.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Sep 25, 2026 | $2,000,000fully sold | 4 | $500K | Debt, Securities on exercise, Convertible NotesRule 506(b) | Form D ↗ |
| May 21, 2021 | Jun 4, 2021 | $4,660,000fully sold | 1 | $4.6M | Equity, Convertible Notes converted in exchange for Series B Preferred Units, in addition to cash paid for Series B Preferred Units.Rule 506(b) | Form D ↗ |
| May 20, 2014 | Jul 9, 2014 | $250,000of $500K target | 1 | $250K | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $6,910,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on EnteroTrack's Form D filed Sep 25, 2026.
Sources
- SECEnteroTrack, LLC filing history
- CompanyPrivacy policy
- CompanyMeet the team
- CompanyEsophageal String Test launch